Zeolites as Ingredients of Medicinal Products
dc.contributor.author | Souza, Iane M. S. | |
dc.contributor.author | García Villén, Fátima | |
dc.contributor.author | Viseras, César | |
dc.contributor.author | Perger, Sibele B. C. | |
dc.date.accessioned | 2023-06-07T18:10:19Z | |
dc.date.available | 2023-06-07T18:10:19Z | |
dc.date.issued | 2023-04-28 | |
dc.identifier.citation | Pharmaceutics 15(5) : (2023) // Article ID 1352 | es_ES |
dc.identifier.issn | 1999-4923 | |
dc.identifier.uri | http://hdl.handle.net/10810/61328 | |
dc.description.abstract | Development of new medicinal products for particular therapeutic treatment or for better manipulations with better quality and less side effects are possible as a result of advanced inorganic and organic materials application, among which zeolites, due to their properties and versatility, have been gaining attention. This paper is an overview of the development in the use of zeolite materials and their composites and modifications as medicinal products for several purposes such as active agents, carriers, for topical treatments, oral formulations, anticancer, the composition of theragnostic systems, vaccines, parenteral dosage forms, tissue engineering, etc. The objective of this review is to explore the main properties of zeolites and associate them with their drug interaction, mainly addressing the advances and studies related to the use of zeolites for different types of treatments due to their zeolite characteristics such as molecule storage capacity, physical and chemical stability, cation exchange capacity, and possibility of functionalization. The use of computational tools to predict the drug—zeolite interaction is also explored. As conclusion was possible to realize the possibilities and versatility of zeolite applications as being able to act in several aspects of medicinal products. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | MDPI | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | zeolite | es_ES |
dc.subject | drug delivery system | es_ES |
dc.subject | modified drug release | es_ES |
dc.subject | novel formulations | es_ES |
dc.title | Zeolites as Ingredients of Medicinal Products | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.date.updated | 2023-05-26T13:20:53Z | |
dc.rights.holder | © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). | es_ES |
dc.relation.publisherversion | https://www.mdpi.com/1999-4923/15/5/1352 | es_ES |
dc.identifier.doi | 10.3390/pharmaceutics15051352 | |
dc.departamentoes | Farmacia y ciencias de los alimentos | |
dc.departamentoeu | Farmazia eta elikagaien zientziak |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).